← Back to Search

Virtual Mindfulness-Based Weight Management for Cancer Survivors

N/A

Recruiting

Led By Lisa Howell, Ph.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 or over

Identified stage I or stage II cancer in remission

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial tests a virtual program to help obese cancer survivors manage their weight and stress better, which may help them stay healthier.

Who is the study for?

This trial is for adult cancer survivors who are in remission from stage I or II cancer, have a BMI of 30 or more, and can perform daily activities with ease to moderate difficulty. Participants must speak English and have access to a device with a camera and reliable internet.Check my eligibility

What is being tested?

The study tests a virtual program combining mindfulness exercises and weight management education aimed at improving wellbeing, stress coping strategies, and promoting weight loss among obese cancer survivors living in rural areas.See study design

What are the potential side effects?

Potential side effects may include discomfort from engaging in new physical activities, emotional distress during mindfulness practices or interviews, skin irritation from medical devices used for monitoring health metrics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My stage I or II cancer is currently in remission.

Select...

I can do most of my daily activities on my own.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of virtual mindfulness and weight management program

General anxiety disorder-7 (GAD-7)

Patient Health Questionnaire (PHQ)-8

Secondary outcome measures

Body composition parameter

Body weight

Daily activity levels - activity

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (virtual mindfulness and weight management)Experimental Treatment9 Interventions

Patients participate in a virtual behavioral weight management program with an integrated mindfulness component consisting of 12, 75-minute virtual group sessions over 12 weeks to help improve mood, coping strategies, stress management, and weight loss. Patents also receive patient education handouts, view behavioral educational PowerPoint presentations over 30 minutes, and wear a Fitbit on study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Behavioral Dietary Intervention

2016

Completed Phase 1

~110

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,452 Total Patients Enrolled

Lisa Howell, Ph.D.Principal InvestigatorMayo Clinic Health System-Franciscan Healthcare

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for participants in this study?

"The trial in question is not taking on new patients at this time. According to the data hosted by clinicaltrials.gov, it was originally posted on September 21st 2023 and last edited a few weeks later, on September 1st 2023. However, 2575 other studies are actively recruiting participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors

2023. "Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06030427.